Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Finerenone
Treatment for Chronic kidney disease due to hypertension
Typical Dosage: 10-20mg daily
Effectiveness
88%
Safety Score
65%
Clinical Trials
20
Participants
13K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-20mg daily
Time to Effect
6-12 months for significant renoprotection
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
29(Treat 29 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$7,000
Monitoring:$1,200
Side Effect Mgmt:$250
Total Annual:$8,450
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$80,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$24,143
Comparison vs Standard care (ACEi/ARB +/- SGLT2i)
Cost Difference
+$8,450/year
More expensive
QALY Difference
+0.60 QALYs
Better outcomes
Dominance
No dominance
Finerenone Outcomes
for Chronic kidney disease due to hypertension
Efficacy Outcomes
Overall Effectiveness
+88%
Response Rate
+35%
Common Side Effects
Hyperkalemia
+12%
Hypotension
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov